A carregar...
Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
BACKGROUND: Irritable bowel syndrome with diarrhea (IBS-D) has limited options for treatment currently, including mainly anti-motility medications, antispasmodics, and antidepressants. This review discusses the properties of a new drug, eluxadoline, a gut-targeting mu- and kappa-opioid receptor agon...
Na minha lista:
| Publicado no: | Clin Exp Gastroenterol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624596/ https://ncbi.nlm.nih.gov/pubmed/28989282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S123621 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|